Mitochondrial Haplogroups Modify the Risk of Developing Hypertrophic Cardiomyopathy in a Danish Population
Open Access
- 5 August 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (8) , e71904
Abstract
Hypertrophic cardiomyopathy (HCM) is a genetic disorder caused by mutations in genes coding for proteins involved in sarcomere function. The disease is associated with mitochondrial dysfunction. Evolutionarily developed variation in mitochondrial DNA (mtDNA), defining mtDNA haplogroups and haplogroup clusters, is associated with functional differences in mitochondrial function and susceptibility to various diseases, including ischemic cardiomyopathy. We hypothesized that mtDNA haplogroups, in particular H, J and K, might modify disease susceptibility to HCM. Mitochondrial DNA, isolated from blood, was sequenced and haplogroups identified in 91 probands with HCM. The association with HCM was ascertained using two Danish control populations. Haplogroup H was more prevalent in HCM patients, 60% versus 46% (p = 0.006) and 41% (p = 0.003), in the two control populations. Haplogroup J was less prevalent, 3% vs. 12.4% (p = 0.017) and 9.1%, (p = 0.06). Likewise, the UK haplogroup cluster was less prevalent in HCM, 11% vs. 22.1% (p = 0.02) and 22.8% (p = 0.04). These results indicate that haplogroup H constitutes a susceptibility factor and that haplogroup J and haplogroup cluster UK are protective factors in the development of HCM. Thus, constitutive differences in mitochondrial function may influence the occurrence and clinical presentation of HCM. This could explain some of the phenotypic variability in HCM. The fact that haplogroup H and J are also modifying factors in ischemic cardiomyopathy suggests that mtDNA haplotypes may be of significance in determining whether a physiological hypertrophy develops into myopathy. mtDNA haplotypes may have the potential of becoming significant biomarkers in cardiomyopathy.Keywords
This publication has 47 references indexed in Scilit:
- Mitochondrial Haplogroups H and J: Risk and Protective Factors for Ischemic CardiomyopathyPLOS ONE, 2012
- The sites and topology of mitochondrial superoxide productionExperimental Gerontology, 2010
- Malignant and benign mutations in familial cardiomyopathies: Insights into mutations linked to complex cardiovascular phenotypesJournal of Molecular and Cellular Cardiology, 2010
- New aspects of impaired mitochondrial function in heart failureJournal of Bioenergetics and Biomembranes, 2009
- Supramolecular organization of protein complexes in the mitochondrial inner membraneBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
- “ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis”—a critical commentaryFree Radical Biology and Medicine, 2008
- Association of the mitochondrial DNA haplogroup J with longevity is population specificEuropean Journal of Human Genetics, 2004
- Mitochondrial Polymorphisms Significantly Reduce the Risk of Parkinson DiseaseThe American Journal of Human Genetics, 2003
- Elevated Levels of 8-iso-Prostaglandin F2αin Pericardial Fluid of Patients With Heart FailureCirculation, 1998
- Hypertrophic CardiomyopathyNew England Journal of Medicine, 1987